Vertaling van "study of oral contraceptive use and risk of myocardial " (Frans → Nederlands) :

(Margolis 2007) Margolis KL, Adami HO, Luo J et al. A prospective study of oral contraceptive use and risk of myocardial
(Margolis 2007) Margolis KL, Adami HO, Luo J et al. A prospective study of oral contraceptive use and risk of myocardial infarction among

(Khader 2003) Khader YS, Rice J, Lefante J, Abueita O. Oral contraceptive use and the risk of myocardial infarction: a metaanalysis. Contraception 2003; 68:11-7
(Khader 2003) Khader YS, Rice J, Lefante J, Abueita O. Oral contraceptive use and the risk of myocardial infarction: a meta-analysis.

drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States
compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data. BMJ

Risk of non-fatal venous thromboembolism in women using oral contraceptives containing
Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone

D’après D.M. Grabrick et al.: Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer.
Naar D.M. Grabrick et al.: Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer.

Oral contraceptive use as a risk factor for premenopausal
Oral contraceptive use as a risk factor for premenopausal breast cancer: